ChemicalBook--->CAS DataBase List--->98631-95-9

98631-95-9

98631-95-9 Structure

98631-95-9 Structure
IdentificationBack Directory
[Name]

Sobuzoxane
[CAS]

98631-95-9
[Synonyms]

e)(ester)
Perazoline
Sobuzoxane
methylpropyl)ester
1,2-bis(4-isobutoxycarbonyloxymethyl-3,5-dioxo-piperazin-1-yl)ethane
1,2-ethanediylbis((2,6-dioxo-4,1-piperazinediyl)methylene)bis(2-carbonicaci
4,4’-ethylenebis(1-(hydroxymethyl)-2,6-piperazinedione)bis(isobutylcarbonat
4,4'-Ethylenebis(2,6-dioxopiperazine-1-methanol)bis(2-methylpropoxyformate)
MST-16, 4,4μ-(1,2-Ethanediyl)bis(1-isobutoxycarbonyloxmethyl-2,6-piperazinedione)
[4-[2-[4-(2-METHYLPROPOXYCARBONYLOXYMETHYL)-3,5-DIOXOPIPERAZIN-1-YL]ETHYL]-2,6-DIOXOPIPERAZIN-1-YL]METHYL 2-METHYLPROPYL CARBONATE
[Molecular Formula]

C22H34N4O10
[MDL Number]

MFCD00866498
[MOL File]

98631-95-9.mol
[Molecular Weight]

514.526
Chemical PropertiesBack Directory
[Melting point ]

128-130°; mp 132-133° (Cai, 1989)
[Boiling point ]

664.9±55.0 °C(Predicted)
[density ]

1.272±0.06 g/cm3(Predicted)
[solubility ]

DMSO: 19 mg/mL
[form ]

solid
[pka]

2.75±0.20(Predicted)
[color ]

White to off-white
Safety DataBack Directory
[WGK Germany ]

2
[RTECS ]

FG1582500
[Toxicity]

LD50 in male, female mice, rats (mg/kg): 807, 960, 877, 567 i.p.; 400, 673, 3025, 2821 s.c.; >5 g/kg orally in all species (Tokiwa)
Hazard InformationBack Directory
[Description]

Sobuzoxane, a novel bis(2,6-dioxopiperazine) derivative, was introduced in Japan for the treatment of malignant lymphoma and adult T-cell IeukemiaQmphoma (ATLL), which is resistant to chemotherapy and has a poor prognosis. Sobuzoxane exhibits 8 broad spectrum of antitumor activity. It is a noncleavable complexstabilizing topoisomerase II inhibitor and exerts its function via interfering with the catalytic activity of the enzyme to result in an irreversible inhibition of cell division by blockade of chromosome condensation and segregation. Due to Its unique mode of cytocidai activity, it has no cross resistance with many currently available anticancer agents. Sobuzoxane is reported to significantly inhibit growth of human colon, lung, gastric, and breast cancers and is in clinical trials for these indications.
[Originator]

Zenyaku Kogyo (Japan)
[Uses]

Sobuzoxane is an inhibitor of DNA topoisomerase II which induces apoptosis.
[Definition]

ChEBI: Sobuzoxane is an organic molecular entity.
[Brand name]

Perazolln
98631-95-9 suppliers list
Company Name: Heterochem  
Telephone: 027-88041443 13072715837
Website: www.hetero-chem.com
Company Name: CONIER CHEM AND PHARMA LIMITED  
Telephone:
Website: http://www.conier.com/
Company Name: Nantong QuanYi Biotechnology Co., Ltd  
Telephone: 0513-66337626 18051384581
Website: https://www.chemhifuture.com/
Company Name: TargetMol  
Telephone: 400-821-0310 15002144251
Website: www.targetmol.cn/
Tags:98631-95-9 Related Product Information
109-01-3 77-85-0 75-56-9 558-30-5 123-91-1 74-84-0 10361-29-2